Postmastectomy Radiation Therapy After TRAM Flap Breast Reconstruction
- 10 March 2004
- journal article
- research article
- Published by Hindawi Limited in The Breast Journal
- Vol. 10 (2), 118-122
- https://doi.org/10.1111/j.1075-122x.2004.21286.x
Abstract
Postmastectomy chest wall and nodal radiation therapy decreases local recurrence and improves disease‐free and overall survival. Immediate transverse rectus abdominis myocutaneous (TRAM) flap breast reconstruction after mastectomy has become more common. We report on our experience of irradiating the chest wall and regional lymph nodes after a TRAM flap reconstruction and describe the acute side effects, flap viability, and cosmetic outcome. Between 1995 and 2000, 22 patients with a median age of 47 years (range 27–61 years) received chest wall radiotherapy following mastectomy and immediate pedicled TRAM flap reconstruction. The indication for radiotherapy included tumor size, involved lymph nodes, or positive margins. All patients received chemotherapy before radiotherapy and three patients also received concurrent chemotherapy. The median dose to the chest wall was 50.4 Gy in 28 fractions of 1.8 Gy using a 6 or 4 MV linear accelerator. The patients were all computed tomography (CT) planned in the treatment position. The patients were immobilized using an alpha cradle. Two tangent fields were used to deliver the dose. On alternating days, a customized bolus was applied to the chest wall that spared the central region where the subsequent nipple reconstruction would be performed. All 22 patients completed 90% of the prescribed chest wall radiotherapy dose. Sixty‐six percent of the patients received treatment without any treatment breaks. Only 10% of the patients developed desquamation of the TRAM flap skin. Thirty percent developed grade II erythema of the TRAM flap. With median follow‐up of 18 months, no TRAM flaps have been lost or required revision. This technique for delivery of radiotherapy to the chest wall in patients who have undergone a mastectomy and immediate TRAM flap reconstruction is well tolerated. The acute toxicity was manageable. There were no TRAM flap losses or revisions performed secondary to the radiotherapy.Keywords
This publication has 15 references indexed in Scilit:
- Comparison of Immediate and Delayed Free TRAM Flap Breast Reconstruction in Patients Receiving Postmastectomy Radiation TherapyPlastic and Reconstructive Surgery, 2001
- The acute effects of postoperative radiation therapy on the transverse rectus abdominis myocutaneous flap used in immediate breast reconstructionInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialThe Lancet, 1999
- Radiation Tolerance of Transverse Rectus Abdominis Myocutaneous-Free Flaps Used in Immediate Breast ReconstructionAmerican Journal of Clinical Oncology, 1998
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- TRAM Flap Anatomy Correlated with a 10-Year Clinical Experience with 556 PatientsPlastic and Reconstructive Surgery, 1995
- Autologous Breast Reconstruction With Use of Transverse Rectus Abdominis Musculocutaneous Flap: Mayo Clinic Experience With 147 CasesMayo Clinic Proceedings, 1994
- Collagen Gene Expression and Wound Strength in Normal and Radiation‐Impaired WoundsThe Journal of Dermatologic Surgery and Oncology, 1993
- The sooner the better: a study of psychological factors in women undergoing immediate versus delayed breast reconstructionAmerican Journal of Psychiatry, 1985